Hematology, Transfusion and Cell Therapy
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ
- PublisherElsevier
- LanguageEnglish
- Publication Time30
- Editorial Review ProcessDouble blind peer review
- LanguageEnglish
- Society/Institute/SponsorAssociação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
- Website URL
- Plagiarism
- Publication Time30
- Waiver Policy
- Editorial Team
- Review ProcessDouble blind peer review
- Review Url
- Author instructions
- License typeCC BY, CC BY-NC-ND
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 14% |
| 4-6 | 15% |
| 7-9 | 35% |
| >9 | 36% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Who is the publisher of Hematology, Transfusion and Cell Therapy? 
The publisher of Hematology, Transfusion and Cell Therapy is Elsevier.
How can I view the journal metrics of Hematology, Transfusion and Cell Therapy on editage?
For the Hematology, Transfusion and Cell Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Hematology, Transfusion and Cell Therapy?
The eISSN number is 2531-1387 and pISSN number is 2531-1379 for Hematology, Transfusion and Cell Therapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Thalassemia, Hemophagocytic lymphohistiocytosis, Cold Agglutinin, Acute chest syndrome, Pediatric population, Intensive care unit, Vaso-occlusive crisis, Cold agglutinin disease.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.